Validating Global Interest and Preparing for Launch Readiness
To assess market needs in the United States and abroad, LuminusMicro management has engaged extensively with surgeons, hospital executives, and distribution partners to demonstrate early prototypes and gather feedback. These interactions have provided strong qualitative support for the continued development of the X1 platform and its future specialty-specific versions.
To enable an efficient and compliant market introduction once regulatory milestones are achieved, LuminusMicro has built an integrated network of experienced medical-device executives, specialized legal and regulatory partners, top-tier distributors, educational collaborators, and U.S.-based manufacturing resources capable of supporting scalable single-use, sterile production.
The company is evaluating opportunities to adapt its microsurgical technology across multiple high-demand specialties, including:
Ear, Nose & Throat (ENTnano)
Orthopedics (Luminus Ortho)
Neuro-Spine (Luminus Neuro)
Women’s Health (Luminus GYN)
Genito-Urinary (Luminus Urinary)
Pulmonary/Thoracic (Luminus Pulmonary)
Cardio & Vascular (Luminus Vascular)
Gastrointestinal (Luminus GI)
Dental (DDS Corp Dental Device Solutions)
Targeted Cancer and Regenerative (Nano Delivery Systems)
Healthcare Data Mining / Al (Med Reference, Inc)
Leveraging its foundation in manufacturing, compliance, and early market research, LuminusMicro is preparing to introduce the first embodiment of its core technology—ENTnano—focused on advancing visualization and therapeutic access within the Ear, Nose, and Throat field, where unmet procedural needs remain high.
